ArticleBMJ open2023

Inhibition of bradykinin in SARS-CoV-2 infection: a randomised, double-blind trial of icatibant compared with placebo (ICASARS).

Melanie Bailey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.